<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_HKU_HongKong_Data_Bio_Bricks_html"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:HKU_HongKong/Data/Bio_Bricks.html">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:HKU_HongKong/Data/Bio_Bricks.html&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:HKU_HongKong/Data/Bio_Bricks.html&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:HKU_HongKong/Data/Bio_Bricks.html&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:HKU_HongKong/Data/Bio_Bricks.html" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:HKU HongKong/Data/Bio Bricks.html</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><P><TITLE>Team:HKU Hong Kong - 2012</TITLE></P><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:HKU HK</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2011.igem.org</H3><DIV id="main"><DIV id="header"><DIV id="buttons"><P> </P><UL id="css3menu2" class="topmenu"><LI class="topfirst"><A href="https://2012.igem.org/Team:HKU_HongKong" style="height:26px;line-height:26px;">  Home  </A></LI><LI class="topmenu"><A href="#" style="height:26px;line-height:26px;">  Team  </A></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Team/About_Us.html">About Us</A></FONT></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Team/Profiles.html">Profiles</A></FONT></LI></UL><LI class="topmenu"><A href="#" style="height:26px;line-height:26px;">  Project  </A></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Project/Background.html">Background</A></FONT></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Project/Future_Implications.html">Future Implications</A></FONT></LI><LI class="topmenu"><A href="#" style="height:26px;line-height:26px;">  Data  </A></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Data/Weekly_Notebook.html">Weekly Notebook</A></FONT></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Data/Bio_Bricks.html">Bio Bricks</A></FONT></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Data/Results.html">Results</A></FONT></LI><LI class="topmenu"><A href="#" style="height:26px;line-height:26px;">  Protocols  </A></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Data/Mol_Protocols.html"> Molecular Cloning </A></FONT></LI><LI><FONT size="10"><A href="https://2012.igem.org/Team:HKU_HongKong/Data/pvdQ_Protocols.html"> pvdQ Expression Analysis </A></FONT></LI><LI class="topmenu"><A href="https://2012.igem.org/Team:HKU_HongKong/Safety.html" style="height:26px;line-height:26px;">  Safety  </A></LI><LI class="toplast"><A href="https://2012.igem.org/Team:HKU_HongKong/Human_Practice.html" style="height:26px;line-height:26px;">  Human Practice  </A></LI><P> </P><P style="text-align: justify"> </P><H2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px"><SPAN style="font-weight: 400; text-decoration: underline"><FONT face="Trebuchet MS" size="6">Bio-bricks:</FONT></SPAN></H2><P style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"> </P><H2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"><SPAN style="color: rgb(35, 35, 35); font-family: Lato, Tahoma, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: rgb(255, 255, 255)">
1)</SPAN><FONT face="Tahoma" size="2"><B>Constitutive Promoter (J23119) + Ribosomal 
Binding Site (B0034) + pvdQ Gene + Double Terminator (B0015)</B></FONT></H2><P style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"> </P><P style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
This biobrick was constructed to test the 
expression of the pvdQ gene amplified by PCR from genomic DNA of Pseudomonas 
aeruginosa. It is an uncontrollable, standard biobrick that can later be used as 
a baseline reference to test whether our future biobricks result in an 
improvement in pvdQ expression level.  The biobrick is a composite part 
consisting of the already prevalent Constitutive Promoter [2006 Berkley], along 
with the newly inserted pvdQ gene. It is also composed of a strong RBS and a 
transcription double terminator. </P><P style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px"><B>Constitutive Promoter (J23119):</B>
This promoter biobrick is the consensus sequence and therefore results in the 
idealized transcription scenario. Since it is a strong promoter and is 
constitutively expressed, it complies with our preliminary goal of testing 
transcription and translation of the pvdQ gene in an AHL-independent manner<SPAN style="font-size: 10pt; font-family: Tahoma">2) </SPAN><FONT color="#232323" size="2" face="Tahoma"><B>LacI Promoter, RBS, LuxR Gene, 
Double Terminator, LuxR Promoter, &amp; RBS (K137076) + pvdQ Gene + Double 
Terminator (B0015) </B></FONT></P><P style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
This biobrick was constructed to test the expression of the pvdQ gene in an environment containing the 3OC<SUB>12</SUB>-HSL 
substrate. However, the synthesis of pvdQ is not exclusively dependent on AHL. 
This is because the LacI+pI promoter that initiates transcription of the LuxR 
gene can be effectively induced by IPTG. Moreover, the LuxR promoter is also 
expressed well in the absence of LuxR and AHL. The biobrick is composed part of 
the already existing K137076 [2008 Caltech] as well as the pvdQ gene and double 
terminator sequence. The first 1,096bp of the K237076 biobrick containing the 
LacI and LuxR promoters, two RBS, and the LuxR gene was amplified using the 
standard Prefix primer and a newly designed Suffix primer. </P><P style="text-align: justify; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
We chose the biobrick K137076 to 
ligate to the pvdQ gene for the following reasons: </P><UL><LI><P style="text-align: justify"><FONT size="2" face="Tahoma" color="#232323"> K137076 
	consists of a strong, continually expressed promoter (R0011) that can, 
	however, be further induced by IPTG. Such a promoter allows us to control 
	the expression of the LuxR protein.   </FONT></P></LI><LI><P style="text-align: justify"><FONT size="2" face="Tahoma" color="#232323">The complex formed when two 
	molecules of LuxR bind to two molecules of AHL, attaches to a palindromic 
	site on the pLuxR to transcribe the pvdQ gene.This pLuxR promoter however 
	causes leaky expression of pvdQ as it can be induced even in the absence of 
	LuxR and AHL.  </FONT></P></LI></UL><P class="MsoNormal" style="text-align: justify"><FONT size="2" face="Tahoma" color="#232323"> </FONT><FONT color="#232323"><B><FONT size="2" face="Tahoma">3). Constitutive </FONT></B><SPAN style="font-size: 10pt; font-family: Tahoma">Promoter</SPAN><B><FONT size="2" face="Tahoma"> 
(pLacI) + Ribosomal Binding Site + LuxR Gene + Double Terminator + LuxR Promoter 
(J09855) + Ribosomal Binding Site (B0034) + pvdQ Gene + Double Terminator 
(B0015)</FONT></B></FONT></P><P style="text-align:justify;text-justify:inter-ideograph"><FONT size="2" face="Tahoma" color="#232323">This biobrick was constructed such 
that</FONT></P><P class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"> </P><P class="MsoNormal" style="text-align: left"><B><FONT size="2" face="Tahoma" color="#232323">4). </FONT><FONT size="2" face="Tahoma" color="#232323">LuxR Promoter (R1062) + Ribosomal 
Binding Site, LuxR Gene, Double Terminator, &amp; Ribosomal Binding Site (amplified 
from K137076) + pvdQ Gene + Double Terminator (B0015)</FONT></B></P><P style="text-align: justify; text-justify: inter-ideograph"><FONT face="Tahoma" size="2" color="#232323">
This final biobrick is entirely an AHL-dependent system, as an identical 
promoter controls the transcription and translation of both the LuxR and the 
pvdQ gene. This LuxR promoter, unlike its Bba_R0062 counterpart, is only weakly 
expressed in the absence of LuxR and AHL. However, a desirable positive feedback 
mechanism is generated upon coupling of AHL with the LuxR protein.  The AHL-LuxR 
complex binds to p<SUB>LuxR</SUB> and upregulates gene expression. As more LuxR 
is expressed, subsequent pairing of the molecules further activates the 
promoter. Thereby, a large yield of pvdQ is obtainable at low cell density. The 
outcome is advantageous as biofilm formation can be interrupted at an early 
stage.  </FONT></P><P style="text-align:justify;text-justify:inter-ideograph"><FONT size="2" face="Tahoma" color="#232323"> </FONT></P><P class="MsoNormal"> </P><P style="text-align: justify"> </P><H2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"> </H2><H2 style="margin:0.7em 0px; text-align: justify; font-variant: normal; vertical-align: baseline; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; padding: 0px; clear:left"> </H2><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:HKU_HongKong/Data/Bio_Bricks.html">http://2012.igem.org/Team:HKU_HongKong/Data/Bio_Bricks.html</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:HKU_HongKong/Data/Bio_Bricks.html" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:HKU_HongKong/Data/Bio_Bricks.html" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:HKU_HongKong/Data/Bio_Bricks.html&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:HKU_HongKong/Data/Bio_Bricks.html&amp;oldid=197348" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>